A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia

Clinical trial NCT05261646 · WITHDRAWN

Trial details

NCT number: NCT05261646
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-Induced Thrombocytopenia

Start date: 2022-04-15
Primary completion: 2025-03-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.